HU896176D0 - Method for producing of protease, reverse transcriptase and endonuclease of retrovirus - Google Patents
Method for producing of protease, reverse transcriptase and endonuclease of retrovirusInfo
- Publication number
- HU896176D0 HU896176D0 HU896176A HU617689A HU896176D0 HU 896176 D0 HU896176 D0 HU 896176D0 HU 896176 A HU896176 A HU 896176A HU 617689 A HU617689 A HU 617689A HU 896176 D0 HU896176 D0 HU 896176D0
- Authority
- HU
- Hungary
- Prior art keywords
- retroviral
- protease
- proteins
- endonuclease
- reverse transcriptase
- Prior art date
Links
- 102100031780 Endonuclease Human genes 0.000 title abstract 4
- 108091005804 Peptidases Proteins 0.000 title abstract 3
- 108010042407 Endonucleases Proteins 0.000 title abstract 2
- 239000004365 Protease Substances 0.000 title abstract 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 title abstract 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 241001430294 unidentified retrovirus Species 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 6
- 230000001177 retroviral effect Effects 0.000 abstract 6
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 208000030507 AIDS Diseases 0.000 abstract 1
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 101710177291 Gag polyprotein Proteins 0.000 abstract 1
- 101710125418 Major capsid protein Proteins 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000010353 genetic engineering Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000012827 research and development Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
- C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
- C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP30942788 | 1988-12-07 | ||
| JP1088411A JP2852431B2 (ja) | 1988-12-07 | 1989-04-06 | レトロウイルスのプロテアーゼ、逆転写酵素及びエンドヌクレアーゼ、並びにこれ等の酵素の製法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU896176D0 true HU896176D0 (en) | 1990-02-28 |
| HUT54412A HUT54412A (en) | 1991-02-28 |
| HU209835B HU209835B (en) | 1994-11-28 |
Family
ID=26429797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU896176A HU209835B (en) | 1988-12-07 | 1989-11-24 | Method for producing of retrovirus protease, reverse transcriptase and integrase |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0372904B1 (hu) |
| AT (1) | ATE112318T1 (hu) |
| AU (1) | AU643942B2 (hu) |
| CA (1) | CA2004646C (hu) |
| DE (1) | DE68918563T2 (hu) |
| DK (1) | DK612889A (hu) |
| HU (1) | HU209835B (hu) |
| MY (1) | MY104975A (hu) |
| NZ (1) | NZ231593A (hu) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0485611B1 (en) * | 1990-05-28 | 1999-03-17 | The Research Foundation For Microbial Diseases Of Osaka University | Method of preparing plasmid having capabilities of expressing and processing after translation of retrovirus gene, plasmid obtained thereby and product of expression thereof |
| WO1992011028A1 (en) * | 1990-12-19 | 1992-07-09 | Epitope, Inc. | Hiv reverse transcriptase vaccine |
| EP0555797A1 (en) * | 1992-02-10 | 1993-08-18 | Becton, Dickinson and Company | General buffer for restriction endonucleases |
| EP0805873B1 (en) * | 1995-01-27 | 1999-09-01 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by The Secretary, Department of Health and Human Services | Methods for sensitive detection of reverse transcriptase |
| US6242187B1 (en) | 1996-01-29 | 2001-06-05 | Virologic, Inc. | Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| DE69739645D1 (de) * | 1996-01-29 | 2009-12-17 | Monogram Biosciences Inc | Verfahren zur Bestimmung antiviraler Wirkstoff Suszeptibilität und Resistenz sowie antivirales Wirkstoff-Screening |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63503356A (ja) * | 1986-05-20 | 1988-12-08 | ザ・トラステイーズ・オブ・コロンビア・ユニヴアーシテイ・イン・ザ・シテイ・オブ・ニユー・ヨーク | ヒトｔ細胞リンパ球向性ウイルス（ｈｔｌｖ‐３）逆転写酵素の発現及びその使用 |
-
1989
- 1989-11-24 HU HU896176A patent/HU209835B/hu not_active IP Right Cessation
- 1989-11-28 MY MYPI89001647A patent/MY104975A/en unknown
- 1989-11-30 NZ NZ231593A patent/NZ231593A/en unknown
- 1989-12-05 EP EP89312662A patent/EP0372904B1/en not_active Expired - Lifetime
- 1989-12-05 AU AU45908/89A patent/AU643942B2/en not_active Ceased
- 1989-12-05 DE DE68918563T patent/DE68918563T2/de not_active Expired - Fee Related
- 1989-12-05 DK DK612889A patent/DK612889A/da not_active Application Discontinuation
- 1989-12-05 CA CA002004646A patent/CA2004646C/en not_active Expired - Fee Related
- 1989-12-05 AT AT89312662T patent/ATE112318T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU4590889A (en) | 1990-08-02 |
| DE68918563T2 (de) | 1995-02-23 |
| DE68918563D1 (de) | 1994-11-03 |
| EP0372904B1 (en) | 1994-09-28 |
| EP0372904A3 (en) | 1991-09-25 |
| DK612889D0 (da) | 1989-12-05 |
| ATE112318T1 (de) | 1994-10-15 |
| HU209835B (en) | 1994-11-28 |
| CA2004646C (en) | 1999-10-05 |
| AU643942B2 (en) | 1993-12-02 |
| DK612889A (da) | 1990-06-08 |
| MY104975A (en) | 1994-07-30 |
| HUT54412A (en) | 1991-02-28 |
| CA2004646A1 (en) | 1990-06-07 |
| EP0372904A2 (en) | 1990-06-13 |
| NZ231593A (en) | 1992-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA19765A (uk) | Фрагмеhт hуклеїhової кислоти, що кодує людський проаполіпопротеїн а-1 | |
| ES2013346A6 (es) | Metodos para producir secuencias y moleculas de adn recombinante, asi como proteinas t4 solubles. | |
| DE3586189D1 (de) | Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute. | |
| FI881185A0 (fi) | Human mangan-superoxiddismutas (hmn-sod). | |
| DK0495896T3 (da) | Vaccine til beskyttelse mod HIV-virusinfektioner, fremgangsmåde til fremstilling heraf og anvendelse heraf som diagnostisk middel og immunterapeutisk middel | |
| FI832825A (fi) | Jaesthybridvektorer och deras anvaendning foer framstaellning av polypeptider | |
| IT1156461B (it) | Procedimento per la produzione di dna complementare rappresentante sequenze virali di rna mediante metodi del dna ricombinante prodotti relativi e loro usi | |
| ES2058566T3 (es) | Sondas de hibridacion para detectar las cepas de neisseria. | |
| GR3022248T3 (en) | Oligonucleotide sequences for amplification of type HIV-2 and SIV retroviruses genomes and their application to in-vitro diagnostic of infections caused by these viruses | |
| EP0485611A4 (en) | Method of preparing plasmid having capabilities of expressing and processing after translation of retrovirus gene, plasmid obtained thereby and product of expression thereof | |
| HU896176D0 (en) | Method for producing of protease, reverse transcriptase and endonuclease of retrovirus | |
| NZ234453A (en) | Recombinant dna encoding urate oxidase, and vector, host, protein and pharmaceutical compositions associated therewith | |
| HK1046535A1 (en) | Human endogenous retrovirus | |
| ATE103980T1 (de) | Das f-protein vom aids-virus enthaltender impfstoff. | |
| DE58909339D1 (de) | Humaner Papillomvirus Typ 57, seine DNA und die davon kodierten Proteine. | |
| MY104530A (en) | Nonreplicating recombinant-made retroviral particles useful as anti-viral agents and as immunogens for pro- phylaxis and therapy against human retroviruses. | |
| PT87940A (pt) | Processo para a preparacao de dna do virus papillom humano tipo 41 e de proteinas por ele codificadas | |
| DK631387D0 (da) | Virusvektor | |
| Saito et al. | Protease, reverse transcriptase and endonuclease of HIV-1 and RSV method for producing these enzymes | |
| TH9629EX (th) | โพรเทเอส, รีเวอร์ส แทรนส์คริพเทส และเอนโดนิวคลี เอสของ ของเรโทรไวรัส และวิธีการสำหรับผลิตเอนไซม์เหล่า นี้ | |
| EP0293792A3 (en) | Human immunodeficiency virus gag-encoded proteins | |
| TH9629A (hu) | ||
| TH21549A (th) | ลำดับเบสของยีนโปรตีนหุ้มห่อของไวรัสโรคใบลายและผิดรูปของมะละกอ | |
| ES2005189A6 (en) | Nucleotide sequences from RESA antigen of Plasmodium falciparum |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HMM4 | Cancellation of final prot. due to non-payment of fee |